TC
PLRX icon

Truvestments Capital’s Pliant Therapeutics PLRX Stock Holding History

Truvestments Capital’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63 Hold
50
– – ﹤0.01% 1140
2025
Q4 		$61 Hold
50
– – ﹤0.01% 996
2025
Q3 		$74 Sell
50
-117
-70% -$179 ﹤0.01% 1003
2025
Q2 		$194 Hold
167
– – ﹤0.01% 927
2025
Q1 		$225 Hold
167
– – ﹤0.01% 990
2024
Q4 		$2.2K Hold
167
– – ﹤0.01% 828
2024
Q3 		$1.87K Buy
+167
New +$2.09K ﹤0.01% 805
2024
Q2 		– Sell
-184
Closed -$2.74K – 554
2024
Q1 		$2.74K Hold
184
– – ﹤0.01% 592
2023
Q4 		$3.33K Hold
184
– – ﹤0.01% 642
2023
Q3 		$3.19K Hold
184
– – ﹤0.01% 555
2023
Q2 		$3.33K Hold
184
– – ﹤0.01% 563
2023
Q1 		$4.89K Buy
+184
New +$5.24K ﹤0.01% 514

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return